WallStreetZenWallStreetZen

AnalystsZegbeh Jallah
Zegbeh Jallah's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 1%
#17 out of 3861 analysts
Average Return
+114.61%
Win Rate
39%7 out of 18
Risk vs Reward
Poor
Good

Zegbeh Jallah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+2,086.21%$0.29$6.34
2020-11-16 -
2021-06-11
Strong Buy
Ideaya Biosciences IncIDYA
+469.48%$4.03$22.95
2020-03-12 -
2021-03-12
Strong Buy
Enanta Pharmaceuticals IncENTA
+38.81%$50.43$70.00
2022-05-11 -
2022-08-16
Strong Buy
Inventiva SaIVA
+21.37%$10.67$12.95
2020-08-04 -
2021-08-04
Strong Buy
Rapt Therapeutics IncRAPT
+13.94%$16.93$19.29
2020-04-12 -
2021-04-13
Strong Buy

Zegbeh Jallah's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Enanta Pharmaceuticals IncENTA
2Strong Buy$70.000.00%Maintains
3 months ago
Syros Pharmaceuticals IncSYRS
1Strong Buy$23.00+2,271.13%Maintains
a year ago
Atyr Pharma IncLIFE
2Strong Buy$21.00+406.02%Maintains
a year ago
Rezolute IncRZLT
1Strong Buy$21.00+577.42%Initiates Coverage On
a year ago
Arvinas IncARVN
1Strong Buy$135.00N/AMaintains
a year ago
Dare Bioscience IncDARE
1Strong Buy$11.00N/AMaintains
a year ago
Ocugen IncOCGN
2Hold$6.00N/ADowngrades
a year ago
Kodiak Sciences IncKOD
2Strong Buy$149.00N/AUpgrades
a year ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$55.00N/AMaintains
a year ago
Applied Genetic Technologies CorpAGTC
2Strong Buy$35.00N/AMaintains
2 years ago
Inventiva SaIVA
1Strong BuyN/AN/AInitiates Coverage On
2 years ago
Clearside Biomedical IncCLSD
1Strong Buy$8.00N/AInitiates Coverage On
2 years ago
Rapt Therapeutics IncRAPT
1Strong Buy$38.00N/AInitiates Coverage On
2 years ago
Ideaya Biosciences IncIDYA
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$20.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.